What if autism isn’t a glitch in the human code but a pattern in the larger field, a ripple of constructive difference emerging where things are becoming too uniform? Intelligence may not be a sealed package behind our eyes but a network effect of bodies, environments, and signals, a distributed resonance rather than a solitary spark. Entanglement and ER = EPR hint at a universe where separation is an approximation, not a boundary; cognition might work the same way. In such a view, neurocognitive diversity would not be an outlier but the field’s own attempt at self-stabilisation, a counterweight injected where homogeneity threatens collapse.
This reframes both awareness and sentience: not possessions of an organ, but properties of a system that includes the organ, the world around it, and the relationships weaving through. In this light, autism as a “field property” isn’t mysticism but an alternative ontology of mind, where difference is not an error but a mechanism for resilience. The field doesn’t “cure” itself but modulates itself, inserting variance where monotony has crept in, much like turbulence keeps a flow alive. Seen this way, diversity is not an accommodation—it’s a stabilising pulse in a larger intelligence whose boundaries are still invisible to us.
Daedelus Kite 
One reply on “Tylenol”
It would be purely speculative—without evidence, only an observation of remote possibility—to wonder whether financial maneuvers might have quietly swirled around Tylenol’s competitors. If a major brand were shaken, the volatility itself would open opportunities, and markets have a way of amplifying uncertainty into profit. To suggest intent would be unsubstantiated, but it remains plausible that such disruption could catalyze an efflorescence of adversarial opportunism in Big Money circles, where risk displaced from one balance sheet often reappears as advantage on another. Strategic inertia, essentially.
Cui bono?
LikeLike